---
figid: PMC6460662__13046_2019_1094_Fig5_HTML
figlink: /pmc/articles/PMC6460662/figure/Fig5/
number: F5
caption: Mechanism of action of anti-BRAF drugs on the RAS signaling pathway. RAS
  activates both the CRAF and the BRAF pathways. Inhibitors for both BRAF and MEK
  are shown. These inhibitors act to prevent cell proliferation and growth of cancer
  cells. Sorafenib, vemurafenib, dabrafenib, cobimetinib, regorafenib, and trametinib
  are all FDA approved for the treatment of cancer
pmcid: PMC6460662
papertitle: Clinical development of targeted and immune based anti-cancer therapies.
reftext: N. A. Seebacher, et al. J Exp Clin Cancer Res. 2019;38:156.
pmc_ranked_result_index: '13819'
pathway_score: 0.9626798
filename: 13046_2019_1094_Fig5_HTML.jpg
figtitle: Mechanism of action of anti-BRAF drugs on the RAS signaling pathway
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6460662__13046_2019_1094_Fig5_HTML.html
  '@type': Dataset
  description: Mechanism of action of anti-BRAF drugs on the RAS signaling pathway.
    RAS activates both the CRAF and the BRAF pathways. Inhibitors for both BRAF and
    MEK are shown. These inhibitors act to prevent cell proliferation and growth of
    cancer cells. Sorafenib, vemurafenib, dabrafenib, cobimetinib, regorafenib, and
    trametinib are all FDA approved for the treatment of cancer
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAP2K2
  - MAPK3
  - RAF1
  - NRAS
  - MAP2K1
  - Tyrosine
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: Tyrosine
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC6460662__F5
redirect_from: /figures/PMC6460662__F5
figtype: Figure
---
